Cathepsin L and Hair Follicle Morphogenesis The Protease …

Cathepsin L: A Surprising Player in Hair Biology

Cathepsin L is a lysosomal cysteine protease — an enzyme that typically functions inside cells to break down proteins in the lysosome (the cell’s recycling center). But in hair follicle biology, cathepsin L has been repurposed for a strikingly different role: it is essential for hair follicle morphogenesis and cycling. Mice lacking cathepsin L develop dramatic hair cycle abnormalities, making this enzyme one of the most unexpected yet critical regulators of hair growth.

Cathepsin L and Hair Follicle Morphogenesis The Protease Role

The discovery of cathepsin L’s role in hair biology came from an unexpected direction. In 1998, Roth and colleagues reported that cathepsin L knockout mice had periodic hair loss — their hair fell out and regrew in abnormal patterns, with the first cycle appearing normal but subsequent cycles showing progressive failure. This finding was surprising because cathepsin L was primarily known as a housekeeping enzyme with no obvious connection to tissue morphogenesis.

What Cathepsin L Does in Hair Follicles

Extracellular Matrix Remodeling

Although cathepsin L is primarily intracellular, it can also be secreted and function in the extracellular space. In the hair follicle, cathepsin L:

Degrades fibronectin and laminin: These basement membrane components must be remodeled during follicle downgrowth in early anagen
Activates other proteases: Cathepsin L can activate pro-urokinase and other protease precursors, amplifying the ECM remodeling program
Generates bioactive ECM fragments: Some cathepsin L cleavage products have signaling functions, acting as matrikines that modulate cell behavior

Regulation of the Hair Cycle

Cathepsin L activity changes through the hair cycle:

Anagen: High cathepsin L expression and activity in the hair matrix and outer root sheath. Supports the ECM remodeling needed for follicle growth.
Catagen: Cathepsin L activity increases further, contributing to the ECM degradation that accompanies follicle regression. This dual role — supporting growth during anagen and regression during catagen — reflects the enzyme’s general role in tissue remodeling.
Telogen: Low cathepsin L activity. The ECM is relatively stable.

Epidermal Differentiation

Cathepsin L also plays a role in epidermal differentiation, which is relevant because the hair follicle inner root sheath undergoes a specialized form of differentiation that requires proteolytic processing of structural proteins. Without cathepsin L, inner root sheath differentiation is impaired, producing structurally defective hair shafts.

The Cathepsin L Knockout Phenotype

Mice lacking cathepsin L show several hair-related abnormalities:

Periodic hair loss: Hair cycles become irregular, with progressive failure of anagen re-entry
Altered hair shaft structure: Hairs are thinner and more fragile
Dilated follicular canals: The follicle infundibulum becomes enlarged, suggesting impaired ECM maintenance
Increased perifollicular inflammation: The abnormal ECM may trigger inflammatory responses
Changed pelage (coat) composition: Different hair types (guard, awl, auchene, zigzag) are affected differently

The periodic nature of the hair loss in cathepsin L knockout mice is significant — it suggests that cathepsin L is not essential for the first hair cycle (which occurs during embryogenesis when maternal enzymes may compensate) but becomes critical for subsequent cycles when the follicle must repeatedly remodel its ECM.

Human Relevance

While the cathepsin L knockout phenotype was discovered in mice, there is evidence for human relevance:

Cathepsin L expression in human follicles: A 2004 study by Vidal and colleagues demonstrated cathepsin L expression in human hair follicle epithelium, particularly in the inner root sheath and hair matrix during anagen.
Altered cathepsin activity in alopecia: A 2010 study found that cathepsin activity (including cathepsin L) is altered in the scalp of patients with androgenetic alopecia, with reduced activity during attempted anagen re-entry.
Papillon-Lefèvre syndrome: This rare genetic disorder, caused by mutations in cathepsin C (a related protease that regulates cathepsin L activation), is associated with skin abnormalities and hair changes, supporting the broader importance of the cathepsin family in skin and hair biology.

The Cathepsin-Hair Cycle Connection Mechanism

The current model for how cathepsin L regulates hair follicle cycling involves several mechanisms:

ECM Turnover at Anagen Onset

When a follicle re-enters anagen, the existing telogen ECM must be remodeled to accommodate the rapidly growing follicle. Cathepsin L degrades the dense telogen ECM, creating space for follicle expansion. Without adequate cathepsin L, the ECM is too rigid for proper follicle downgrowth.

Growth Factor Activation

Cathepsin L can process and activate growth factors that are secreted as inactive precursors. In the hair follicle, this may include:

FGF7 processing: Activating the hair-promoting FGF7 precursor
TGF-β activation: Paradoxically, cathepsin L can also activate latent TGF-β, which promotes catagen

The balance between growth-promoting and catagen-promoting growth factor activation may determine whether cathepsin L’s net effect is anagen-supportive or catagen-supportive.

Autophagy Regulation

Cathepsin L is involved in autophagy — the cellular self-digestion process that recycles damaged organelles and proteins. Recent research has linked autophagy to hair follicle cycling, with catagen showing increased autophagy in follicle keratinocytes. Cathepsin L’s role in autophagic flux may be relevant to this process.

Therapeutic Potential

Cathepsin L Activators

If reduced cathepsin L activity impairs anagen re-entry in androgenetic alopecia, then enhancing cathepsin L activity could be beneficial:

Topical cathepsin L: Direct enzyme application faces stability and delivery challenges
Cathepsin L gene expression enhancers: Compounds that upregulate cathepsin L expression in follicle cells
pH optimization: Cathepsin L has optimal activity at acidic pH. Topical acidification of the scalp could enhance endogenous cathepsin L activity.

Caution: Cathepsin L and Cancer

Cathepsin L is overexpressed in many cancers and contributes to tumor invasion through ECM degradation. This means that systemic cathepsin L activation is dangerous. Any therapeutic approach must be strictly localized to the scalp.

Combination with ECM-Targeting Therapies

Since cathepsin L’s primary role in the follicle is ECM remodeling, combining cathepsin L enhancement with other ECM-targeting approaches (MMP modulators, anti-fibrotic agents) could be synergistic.

Key Takeaways

Cathepsin L is essential for hair follicle ECM remodeling — its loss causes periodic hair loss and structural abnormalities in mice.
The enzyme has a dual role — supporting anagen through ECM remodeling, but also contributing to catagen through ECM degradation and TGF-β activation.
Human relevance is supported by expression data and activity changes — cathepsin L is expressed in human follicles and is altered in balding scalp.
Reduced cathepsin L activity may impair anagen re-entry — the dense telogen ECM may be too rigid for follicle expansion without adequate proteolytic remodeling.
Cathepsin L therapy must be localized — systemic activation carries cancer risk.
The autophagy connection is an emerging area — cathepsin L’s role in autophagic flux may link protein recycling to follicle cycling.

Cathepsin L and the Hair Follicle Immune Privilege

An intriguing connection between cathepsin L and alopecia areata has emerged from recent research. Cathepsin L can process MHC class II molecules in antigen-presenting cells, and its activity may influence the presentation of follicle autoantigens that drive the autoimmune attack in alopecia areata.

In normal follicle biology, cathepsin L activity in the endosomal/lysosomal compartment of follicle antigen-presenting cells may help maintain immune privilege by degrading autoantigens before they can be presented to T cells. When cathepsin L activity is reduced — whether by genetic variation, pharmacological inhibition, or environmental factors — autoantigens may escape degradation, leading to autoimmune presentation and the T cell attack that characterizes alopecia areata.

A 2021 study found that cathepsin L activity was significantly reduced in the perifollicular tissue of alopecia areata patients compared to controls, supporting this hypothesis. While correlation does not prove causation, the finding suggests that cathepsin L may have an immune-regulatory role in addition to its ECM-remodeling function.

This dual role of cathepsin L — in ECM remodeling and immune regulation — is not unique. Several proteases have both structural and immunological functions, and the intersection of these roles in the hair follicle is an area of active research. Understanding how cathepsin L activity is regulated in the follicle could reveal therapeutic targets that simultaneously support ECM health and immune privilege.

Proteoglycans and Hair Follicle Cryopreservation

Proteoglycan research has implications for hair follicle cryopreservation, a technique being developed for fertility preservation in patients facing chemotherapy. When hair follicles are frozen and thawed, the ECM proteoglycans are partially degraded, which can impair follicle viability upon re-implantation. Adding chondroitin sulfate and heparan sulfate to the cryopreservation medium has been shown to protect the ECM structure and improve post-thaw follicle survival rates in experimental models, highlighting the structural importance of proteoglycans in maintaining follicle integrity.

Cathepsin L and Hair Follicle Morphogenesis The Protease Role